UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

~~FORM~~Form 6-K

REPORT OF FOREIGN PRIVATE ~~ISSUER PURSUANT TO~~ ~~RULE 13a-16 OR 15d-16 UNDER THE~~ ISSUER

~~SECURITIES~~PURSUANT ~~EXCHANGE~~TO ~~ACT~~RULE 13a-16 OR ~~OF 1934~~15d-16

~~For~~UNDER ~~the~~THE ~~month~~SECURITIES EXCHANGE ofACT ~~May~~OF ~~2025~~1934

For the month of February 2026

Commission File Number: 001-38245

Akso Health Group

(~~Exact~~Translation ~~name~~ of registrant’s name asinto ~~specified in its charter~~English)

Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building,

No. 44, Moscow Road, Qianwan Bonded Port Area,

Qingdao Pilot Free Trade Zone, China (Shandong)

Tel: +86 152 1005 4919

(Address of ~~Principal~~principal executive ~~Executive Offices~~office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~Change~~Interim ~~of Chief~~ Financial ~~Officer~~Statements

~~On April 24, 2025, Ms. Rui (Kerrie) Zhang notified~~ Akso Health Group ~~(the~~is ~~“Company”)~~furnishing ofthis ~~her~~Form 6-K ~~resignation~~to asprovide ~~Chief~~six-month ~~Financial~~interim ~~Officer~~financial ~~(“CFO”)~~statements ~~of the Company, effective as of April 24, 2025. Ms. Rui (Kerrie) Zhang has advised the Company that her resignation was due to personal reasons~~ and ~~not~~incorporate asuch ~~result~~financial statements ofinto ~~any disagreement with~~ the Company’s onregistration ~~any~~statements ~~matter~~referenced ~~related to the operations, policies, or practices of the Company~~below.

ToThis ~~fill~~Form 6-K ~~the~~is ~~vacancy~~hereby ~~created~~incorporated by ~~Ms.~~reference ~~Rui~~into ~~(Kerrie) Zhang’s departure,~~ the ~~Board~~registration statements of ~~Directors~~the ofCompany (the “Company”) ~~appointed Mr~~on Form S-8 (Registration No. 333-223951) ~~Zhongliang~~and ~~Xie~~ on Form F-3, as ~~CFO,~~amended ~~effective~~(Registration ~~April~~No. 24No. 277351), ~~2025.~~to ~~The~~the ~~appointment of~~extent ~~Mr.~~not ~~Xie~~superseded asby ~~CFO~~documents ~~has~~or areports ~~term~~subsequently offiled ~~one~~or ~~year~~furnished ~~and~~by the ~~may~~Company beunder ~~extended~~the ~~for~~Securities ~~successive~~Act ~~one-year~~of ~~terms~~1933, ~~subject~~as toamended, ~~earlier resignation~~ or ~~removal. The~~the ~~biographical~~Securities ~~information~~Exchange Act of ~~Mr.~~1934, ~~Xie~~as ~~is set forth below~~amended.

~~Mr.~~Financial ~~Zhongliang~~Statements Xie has served as the General Manager of Zhongxingcai Guanghua Certified Public Accountants Shaanxi Branch since 2019. He previously served as the General Manager of Beijing Xinghua Certified Public Accountants Xi’an Branch from 2008 to 2018, and ~~as the Finance Manager of Zhongyi Far East Import & Export Co~~Exhibits., Ltd. from 2005 to 2008. Mr. Xie has also been the signing CPA and lead audit partner for several bond issuance and annual report projects in China. In addition, he has served as the lead audit partner for the listing and annual reports of numerous companies listed on the National Equities Exchange and Quotations (NEEQ) of China. Mr. Xie is a Chinese Certified Public Accountant (CPA), Certified Asset Appraiser, Chinese Certified Cost Engineer, and a fellow of the International Association of Accountants (FAIA).

~~There are no family relationships between Mr~~Exhibits. Zhongliang Xie and any director of the Company. To the best knowledge of the Company, there is no understanding or arrangement between Mr. Xie and any other person pursuant to which he was appointed as the CFO of the Company.

Exhibit No.		Description
99.1		Unaudited Interim Consolidated Financial Statements as of September 30, 2025 and for the Six Months Ended September 30, 2025 and 2024
99.2		Operating and Financial Review and Prospects in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended September 30, 2025 and 2024
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

~~SIGNATURES~~SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, ~~thereunto~~ hereunto duly authorized.

	Akso Health Group
Dated: February 10, 2026	Akso Health Group
	By:	/s/ Yilin (Linda) Wang
	~~Name:~~	~~Yilin (Linda) Wang~~Name:	Yilin (Linda) Wang
	~~Title:~~	~~Chief Executive Officer~~Title:	Chief Executive Officer
Date: May 1, 2025

Filing Compare · Akso Health Group